clinical trial · NCT07401316
Circulating Tumor DNA in Stage I, II, and III Germ-Cell Tumors
Indiana University·N/A·not yet recruiting·n = 130
Germ Cell Cancer MetastaticWhole blood for ctDNA
brief summary
This study will evaluate the utility of ctDNA detection in patients with high-risk stage I, stage II, and stage III germ cell tumor disease to develop a tool for post-treatment cancer cell detection.
started
Mar 1, 2026
primary completion
Sep 1, 2032
completion
Dec 1, 2032
last updated
Mar 20, 2026
detailed description
This is a specimen collection study where patients with high-risk stage I germ cell tumor, clinical stage II germ cell tumor, and clinical stage III germ cell tumor will be evaluated for ctDNA.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol